

FDA approved for acute bronchitis , Clavulanic Acid prevents Amoxycillin from 13-Lactamase degradation & effectively Extended microbial Spectrum ,Most active 3-Lactam agent pneumococci, 3-Lactamase producing Haemophilus influenzae & Moraxella catarrhalis Antimicr , Achieves superior cure rates as compared with Cefuroxime axetil in acute exacerbation of acute bronchitis, Achieves superior cure rates as compared with Cefaclor in acute urinary tract Infections.
Amoxycillin 250mg + Clavulanic Acid 125mg Tablets
| Pack Size | |
|---|---|
| Product Form | |
| Packing Type | |
| Drug Class | |
| Category Area | |
| Medicinal Form | |
| Tax Applicable |
Content missing